Lupin's Glycerol Phenylbutyrate Receives FDA Approval Status
The FDA has granted an approval status of 'AP' for Lupin's application ANDA207694 for Glycerol Phenylbutyrate.
Therapeutic Area
Therapeutic area intelligence for Urea Cycle Disorder with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.